ATG4B has been reported as an oncogene in various cancer cells, including osteosarcoma, chronic myeloid leukemia (CML), human epidermal growth factor receptor 2 (HER2)-positive breast, and colorectal cancer cells [16,17,18,19]. This evidence concerns the gene ERBB2 and osteosarcoma.